155 related articles for article (PubMed ID: 28849235)
1. Lung cancer suppressor gene GPRC5A mediates p53 activity in non‑small cell lung cancer cells in vitro.
Jin E; Wang W; Fang M; Wang L; Wu K; Zhang Y; Zhang S; Ma S
Mol Med Rep; 2017 Nov; 16(5):6382-6388. PubMed ID: 28849235
[TBL] [Abstract][Full Text] [Related]
2. GPRC5a suppresses the proliferation of non-small cell lung cancer under wild type p53 background.
Er J; Chao L; Yiwei L; Feng X; Fei Z; Kan W; Ruifei X
Exp Lung Res; 2020 Sep; 46(7):226-233. PubMed ID: 32410473
[No Abstract] [Full Text] [Related]
3. Overexpression of microRNA‑125a‑3p effectively inhibits the cell growth and invasion of lung cancer cells by regulating the mouse double minute 2 homolog/p53 signaling pathway.
Li S; Li X; Zhao H; Gao M; Wang F; Li W
Mol Med Rep; 2015 Oct; 12(4):5482-6. PubMed ID: 26151241
[TBL] [Abstract][Full Text] [Related]
4. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
5. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
6. Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
Zhang L; Li L; Gao G; Wei G; Zheng Y; Wang C; Gao N; Zhao Y; Deng J; Chen H; Sun J; Li D; Zhang X; Liu M
Int J Cancer; 2017 Jun; 140(12):2734-2747. PubMed ID: 28316092
[TBL] [Abstract][Full Text] [Related]
7. GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development.
Song H; Sun B; Liao Y; Xu D; Guo W; Wang T; Jing B; Hu M; Li K; Yao F; Deng J
Int J Cancer; 2019 Feb; 144(4):777-787. PubMed ID: 29992578
[TBL] [Abstract][Full Text] [Related]
8. β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.
Li J; JunYu ; Liu A; Wang Y
Lung Cancer; 2014 Nov; 86(2):144-50. PubMed ID: 25204604
[TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Merm1/Wbscr22 attenuates sensitivity of H460 non-small cell lung cancer cells to SN-38 and 5-FU without alteration to p53 expression levels.
Yan D; Zheng X; Tu L; Jia J; Li Q; Cheng L; Wang X
Mol Med Rep; 2015 Jan; 11(1):295-302. PubMed ID: 25352209
[TBL] [Abstract][Full Text] [Related]
11. Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor.
Chen Y; Deng J; Fujimoto J; Kadara H; Men T; Lotan D; Lotan R
Cancer Res; 2010 Nov; 70(21):8917-26. PubMed ID: 20959490
[TBL] [Abstract][Full Text] [Related]
12. P53 Regulation-Association Long Non-Coding RNA (LncRNA PRAL) Inhibits Cell Proliferation by Regulation of P53 in Human Lung Cancer.
Su P; Wang F; Qi B; Wang T; Zhang S
Med Sci Monit; 2017 Apr; 23():1751-1758. PubMed ID: 28396580
[TBL] [Abstract][Full Text] [Related]
13. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.
Sung HY; Wu HG; Ahn JH; Park WY
Int J Radiat Biol; 2010 Sep; 86(9):780-90. PubMed ID: 20597837
[TBL] [Abstract][Full Text] [Related]
14. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
[TBL] [Abstract][Full Text] [Related]
15. Human 8-oxoguanine DNA glycosylase suppresses the oxidative stress induced apoptosis through a p53-mediated signaling pathway in human fibroblasts.
Youn CK; Song PI; Kim MH; Kim JS; Hyun JW; Choi SJ; Yoon SP; Chung MH; Chang IY; You HJ
Mol Cancer Res; 2007 Oct; 5(10):1083-98. PubMed ID: 17951408
[TBL] [Abstract][Full Text] [Related]
16. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.
Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z
J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730
[TBL] [Abstract][Full Text] [Related]
17. Bergapten induces G1 arrest of non‑small cell lung cancer cells, associated with the p53‑mediated cascade.
Chiang SR; Lin CS; Lin HH; Shieh PC; Kao SH
Mol Med Rep; 2019 Mar; 19(3):1972-1978. PubMed ID: 30628674
[TBL] [Abstract][Full Text] [Related]
18. Differential apoptotic effects of novel quinuclidinone analogs 8a and 8b in normal and lung cancer cell lines.
Malki A; Bergmeier S
Anticancer Res; 2011 Apr; 31(4):1345-57. PubMed ID: 21508385
[TBL] [Abstract][Full Text] [Related]
19. Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.
Zhong S; Yin H; Liao Y; Yao F; Li Q; Zhang J; Jiao H; Zhao Y; Xu D; Liu S; Song H; Gao Y; Liu J; Ma L; Pang Z; Yang R; Ding C; Sun B; Lin X; Ye X; Guo W; Han B; Zhou BP; Chin YE; Deng J
Cancer Res; 2015 May; 75(9):1801-14. PubMed ID: 25744720
[TBL] [Abstract][Full Text] [Related]
20. HIST1H3D: A promising therapeutic target for lung cancer.
Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN
Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
